Navigation Links
Environmental factors in Tiny Tim's near fatal illness
Date:3/16/2012

Le Bonheur Professor Russell Chesney, M.D. believes he knows what was ailing Tiny Tim, the iconic character from Charles Dickens' "A Christmas Carol." Based on detailed descriptions of both the symptoms and living conditions of 18th century London, Dr. Chesney hypothesizes that Tiny Tim suffered from a combination of rickets and tuberculosis (TB). His findings were published in the March 5 edition of Archives of Pediatrics and Adolescent Medicine.

Dr. Chesney noted during the time the novel was written, 60 percent of children in London had rickets and nearly 50 percent displayed signs of TB. He says this is due to crowded living conditions, poor diets, filth and low exposure to sunlight. The coal-burning city of London in addition to particles from a Indonesian volcanic eruption contributed to blackened skies for many years.

Both rickets and TB can be improved and indeed cured through increased exposure to Vitamin D, which can be obtained through exposure to sunlight and a balanced diet.

As the Ghost of Christmas Present showed Ebenezer Scrooge, Tiny Tim's condition would be fatal without a different course for the boy. According to Dr. Chesney's research, Scrooge could have ensured an improved diet, sunshine exposure and cod liver oil (a common supplement of the day high in Vitamin D) through improved generosity to Bob Cratchit and his family.


'/>"/>
Contact: Sara Burnett
sara.burnett@lebonheur.org
901-287-5162
Le Bonheur Children's Hospital
Source:Eurekalert

Page: 1

Related biology news :

1. Reproductive health providers should discuss environmental exposure risks with patients
2. Effects of environmental toxicants reach down through generations
3. Can industrial parks be more environmentally friendly?
4. Research examines environmental triggers altering gene function in CFS patients
5. Environmental pollutant linked with overweight
6. Create effective new global environmental agency, ministers urged
7. Ocean microbe communities changing, but long-term environmental impact is unclear
8. NIST releases 2 new SRMs for monitoring human exposure to environmental toxins
9. GW researcher and colleagues identify environmental exposure to organochlorines may impact male reproduction
10. New EPA air quality rules outweigh costs and provide major health and environmental benefits
11. Study of Yellowstone wolves improves ability to predict their responses to environmental changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
(Date:11/29/2016)... 2016 BioDirection, a privately held medical device ... objective detection of concussion and other traumatic brain injury ... a meeting with the U.S. Food and Drug Administration ... Package. During the meeting company representatives reviewed plans for ... to commencement of a planned pilot trial. ...
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... control cells — optogenetics — is key to exciting advances in the study ... spatially patterned light projected via free-space optics stimulates small, transparent organisms and excites ...
(Date:12/8/2016)... Mass (PRWEB) , ... December 08, 2016 , ... ... genetic data bioInformatics portal. In response to client demand KbioBox developed a sophisticated ... edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
Breaking Biology Technology: